Highly significant interactions were also identified for Smoking status (Yes vs No: P-interaction<0.0001), the presence of Brain metastasis (Yes vs No: P-interaction=0.0124), and consistently across TMB subgroups (TMB<10 vs TMB≥10: P-interaction = 0.0330; TMB<20 vs TMB≥20: P-interaction = 0.0192).
← all excerpts
Efficacy of PD-1/PD-L1 plus CTLA-4 inhibitors in advanced/metastatic NSCLC: a meta-analysis based on RCTs.
3
—
—
The sentences
Notably, although subgroup analyses indicated potential differences in treatment efficacy based on histology, sex, ECOG status, PD-L1 expression, and liver metastasis, formal interaction tests failed to reach statistical significance.
Smokers experienced a significant improvement in OS, while non-smokers did not benefit even showed a trend towards deterioration.